
Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology
Author(s) -
Mandy Spaan,
Alexandra W. van den Belt–Dusebout,
Cornelis B. Lambalk,
Hester H. van Boven,
R. Schats,
Marian Kortman,
Frank J. Broekmans,
Joop S.E. Laven,
Evert J. P. van Santbrink,
D.D.M. Braat,
Lucette A. J. van der Westerlaken,
Ben J Cohlen,
Astrid E. P. Cantineau,
J.M.J. Smeenk,
Minouche M. van Rumste,
Mariëtte Goddijn,
Ron J.T. van Golde,
Paul A. M. Meeuwissen,
C.J.C.M. Hamilton,
Gabriële M Ouwens,
Miranda A. Gerritsma,
Michael Schaapveld,
Curt W. Burger,
Flora E. van Leeuwen
Publication year - 2020
Publication title -
journal of the national cancer institute
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.797
H-Index - 356
eISSN - 1460-2105
pISSN - 0027-8874
DOI - 10.1093/jnci/djaa163
Subject(s) - medicine , ovarian cancer , hazard ratio , population , assisted reproductive technology , gynecology , obstetrics , confidence interval , miscarriage , pregnancy , infertility , cancer , biology , genetics , environmental health
Long-term effects of assisted reproductive technology (ART) on ovarian tumor risk are unknown.